Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

User: Guest

Title:: Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
Document type:: Zeitschriftenaufsatz
Author(s):: Wolf, Eva ; Boesecke, Christoph ; Balogh, Annamaria ; Bidner, Helen ; Cordes, Christiane ; Heiken, Hans ; Krznaric, Ivanka ; Kümmerle, Tim ; Stellbrink, Hans-Jürgen ; Schneider, Jochen ; Spinner, Christoph D.
Keywords:: Short Report ; Dolutegravir ; Darunavir ; HIV drug resistance ; Integrase inhibitors ; Protease inhibitors
Journal title:: AIDS Research and Therapy
Year:: 2021
Journal volume:: 18
Journal issue:: 1
Fulltext / DOI:: doi:10.1186/s12981-021-00384-6
Publisher:: BioMed Central
E-ISSN:: 1742-6405
Date of publication:: 08.09.2021
BibTeX

Occurrences: